2026-01-22 01:35:00 — Celerion is experiencing technical issues with its eReg portal for users on mobile devices.
Celerion has alerted users to technical difficulties accessing study information via mobile devices, advising a temporary workaround.
- Celerion’s eReg portal is currently experiencing technical issues for mobile device users.
- Users are advised to access the portal using a desktop device to view study opportunities and profile details.
- The company has not specified a timeline for resolving the issue.
Celerion is currently experiencing technical problems with its eReg portal that affect users attempting to access the platform via mobile devices, the company said. The issue prevents mobile users from viewing study opportunities and accessing details within their profiles.
In a notice to users, Celerion recommended logging in to the eReg portal using a desktop device as a temporary solution. The company thanked users for their patience and understanding, but did not provide a specific timeframe for when the mobile access issues would be resolved.
What This Means for You
Individuals interested in participating in clinical research studies sponsored by Celerion and who typically use a mobile device to browse opportunities will need to switch to a desktop or laptop computer to access the eReg portal. This disruption could delay the application process for those relying on mobile access. Those already enrolled in studies are not directly impacted, according to the notice.
The eReg portal serves as a central hub for potential study participants to find and apply for clinical trials conducted by Celerion, a contract research organization. The company conducts early clinical research, including first-in-human studies, for pharmaceutical and biotechnology companies.
